| Literature DB >> 29412740 |
Hila Naaman1, Tatiana Rabinski1,2, Avi Yizhak3, Solly Mizrahi3, Yonat Shemer Avni1,4, Ran Taube1, Bracha Rager1, Yacov Weinstein1, Glenn Rall5, Jacob Gopas1,6, Rivka Ofir1,2.
Abstract
In this study, we found that the measles virus (MV) can infect human-induced pluripotent stem cells (hiPSCs). Wild-type MV strains generally use human signaling lymphocyte activation molecule (SLAM; CD150) as a cellular receptor, while vaccine strains such as the Edmonston strain can use both CD150 and CD46 as receptors. It is not yet known how early in the embryonal differentiation stages these receptors are expressed. We established two hiPSCs (BGU-iPSCs and EMF-iPSCs) which express CD46 and CD150. Both cell types can be infected by MV to form persistent, noncytopathic cell lines that release infectious MV particles. Following MV persistent infection, BGU-iPSCs and EMF-iPSCs remain pluripotent and can differentiate in vitro into the three germ layers. This includes cells expressing the neuronal differentiation markers: NF68 and miRNA-124. Since the MV does not integrate into the cell's genome, it can be utilized as a vehicle to systematically introduce genes into iPSC, to dissect and to define factors regulating lineage differentiation.Entities:
Keywords: human-induced pluripotent stem cells; measles virus; persistent infection
Mesh:
Substances:
Year: 2018 PMID: 29412740 PMCID: PMC5804099 DOI: 10.1089/cell.2017.0034
Source DB: PubMed Journal: Cell Reprogram ISSN: 2152-4971 Impact factor: 1.987